Quarterly Result17 Aug 2026, 08:56 am
Veerhealth Care Reports 388% YoY Revenue Growth in Q1FY27
AI Summary
Veerhealth Care Limited announced its Q1FY27 unaudited financial results, showcasing significant year-over-year growth. Total revenues surged by 388.13% to ₹25.09 Crore, EBITDA grew by 233.87% to ₹2.07 Crore, and PAT increased by 412.50% to ₹1.23 Crore. The company also highlighted several key orders, including ₹293 Lakhs for body care products from a New York-based company and ₹1824.40 Lakhs for skincare products from an Indian FMCG major. USFDA clearance for OTC products and advanced discussions for exports to Russia were also noted. Veerhealth Care anticipates total income of ₹105 crores with PAT of ₹5-6 crores in FY26-27 and ₹156 crores with PAT of ₹9-10 crores in FY27-28.
Key Highlights
- Q1FY27 revenue up 388% YoY to ₹25.09 Cr.
- PAT grew 412% YoY to ₹1.23 Cr.
- Secured significant export orders and USFDA clearance.
- Projecting ₹105 Cr income and ₹5-6 Cr PAT for FY26-27.
- Expanding global footprint and product offerings.
Price Impact
More from VEERHEALTH